283 related articles for article (PubMed ID: 23273887)
21. The simultaneous appearance of a nasal natural killer-cell lymphoma and acute myelogenous leukemia.
Van Crombrugge L; De Vos G; Vanclooster C; Lemmerling M; Kerre T
B-ENT; 2012; 8(1):49-52. PubMed ID: 22545391
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and management of natural killer-cell malignancies.
Ishida F; Kwong YL
Expert Rev Hematol; 2010 Oct; 3(5):593-602. PubMed ID: 21083476
[TBL] [Abstract][Full Text] [Related]
23. Nasal extranodal natural killer T cell lymphoma: an atypical presentation.
Sharma A; Dandekar M; Deshmukh S; Dabholkar J
J Laryngol Otol; 2011 Nov; 125(11):1181-4. PubMed ID: 21733277
[TBL] [Abstract][Full Text] [Related]
24. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
25. [Nasal type natural killer/T cell lymphoma: case series and literature review].
Düzlü M; Ant A; Tutar H; Karamert R; Şahin M; Sayar E; Cesur N
Kulak Burun Bogaz Ihtis Derg; 2016; 26(4):241-7. PubMed ID: 27405082
[TBL] [Abstract][Full Text] [Related]
26. T/NK cell lymphoma presenting as a "blocked nose".
Ketharanathan N; van Kipshagen PJ; Vasmel W; Barbé E; de Vries N
Eur Arch Otorhinolaryngol; 2008 Sep; 265(9):1131-4. PubMed ID: 18188576
[TBL] [Abstract][Full Text] [Related]
27. When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type?
Kim SJ; Oh SY; Hong JY; Chang MH; Lee DH; Huh J; Ko YH; Ahn YC; Kim HJ; Suh C; Kim K; Kim WS
Ann Oncol; 2010 May; 21(5):1058-63. PubMed ID: 19850636
[TBL] [Abstract][Full Text] [Related]
28. Delayed Diagnosis of a Nasal Type Lymphoma Misdiagnosed as Persistent Sinusitis.
Celentano A; Mascolo M; Cirillo N; De Rosa G; Mignogna MD
J Adolesc Young Adult Oncol; 2017 Jun; 6(2):381-384. PubMed ID: 28061034
[TBL] [Abstract][Full Text] [Related]
29. Extranodal natural killer/T-Cell lymphoma: A population-based comparison of sinonasal and extranasal disease.
Vazquez A; Khan MN; Blake DM; Sanghvi S; Baredes S; Eloy JA
Laryngoscope; 2014 Apr; 124(4):888-95. PubMed ID: 24114591
[TBL] [Abstract][Full Text] [Related]
30. [Extra-nodal NK/T-cell lymphoma, nasal type presenting as orbital cellulitis].
Amri GE; Zalagh M; Benariba F
Pan Afr Med J; 2018; 31():8. PubMed ID: 30918537
[TBL] [Abstract][Full Text] [Related]
31. Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type.
Liang R
Br J Haematol; 2009 Oct; 147(1):13-21. PubMed ID: 19604234
[TBL] [Abstract][Full Text] [Related]
32. [Angiocentric T/NK cell lymphoma: a special clinical-pathological entity of lethal midline granuloma. A case report].
Koch M; Blatterspiel GJ; Niedobitek G; Constantinidis J
Laryngorhinootologie; 2001 Jul; 80(7):410-5. PubMed ID: 11488153
[TBL] [Abstract][Full Text] [Related]
33. Nasopharyngeal/nasal type NK/T lymphoma: analysis of 23 cases and current review of the literature.
Youssef YB; Bougmiza I; Bouabid Z; Achour B; Regaieg H; Sriha B; Belkadhi M; Omri HE; Khelif A
Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):275-83. PubMed ID: 22991988
[TBL] [Abstract][Full Text] [Related]
34. Nasal NK/T-cell lymphoma in the paediatric population. Two case reports.
Zeglaoui I; Belcadhi M; Sriha B; Bouzouita K
B-ENT; 2009; 5(2):119-23. PubMed ID: 19670600
[TBL] [Abstract][Full Text] [Related]
35. [Sinonasal extranodal natural killer/T-cell lymphoma: a case report and review of recent developments in the management].
Dağoğlu RN; Ozdemir O; Ergen A; Ağaoğlu FY
Kulak Burun Bogaz Ihtis Derg; 2012; 22(3):164-71. PubMed ID: 22663927
[TBL] [Abstract][Full Text] [Related]
36. The extent of local tumor invasion predicts prognosis in stage IE nasal natural killer/T-cell lymphoma: a novel T staging system for risk stratification.
Bi XW; Zhang WW; Li ZM; Huang JJ; Xia Y; Sun P; Wang Y; Jiang WQ
Ann Hematol; 2015 Sep; 94(9):1515-24. PubMed ID: 25924921
[TBL] [Abstract][Full Text] [Related]
37. Radiotherapy combined with chemotherapy versus radiotherapy alone for early stage nasal natural killer/T-cell lymphoma: a meta-analysis.
Zhang B; Zhu F; Liu X; Zhao J; Li M; Li Y; Huang J; Zou L; Chang Q
J Chemother; 2016; 28(1):65-71. PubMed ID: 25971360
[TBL] [Abstract][Full Text] [Related]
38. [Incidence and treatment of extranodal natural killer/T-cell lymphoma nasal type. Hungarian experiences].
Bakos A; Szomor Á; Schneider T; Miltényi Z; Marton I; Borbényi Z; Pammer J; Krenács L; Bagdi E; Piukovics K
Orv Hetil; 2017 Oct; 158(41):1635-1641. PubMed ID: 29025287
[TBL] [Abstract][Full Text] [Related]
39. Primary spinal natural killer/T-cell lymphoma successfully treated with concurrent chemoradiotherapy and autologous stem cell transplantation.
Kim KT; Kim YB; Kim HJ; Cha YJ; Lee SJ; Park E
Spine (Phila Pa 1976); 2012 May; 37(10):E629-32. PubMed ID: 22089400
[TBL] [Abstract][Full Text] [Related]
40. A case of primary cutaneous extranodal natural killer/t-cell lymphoma, nasal type, with a 22-year indolent clinical course.
Zuriel D; Fink-Puches R; Cerroni L
Am J Dermatopathol; 2012 Apr; 34(2):194-7. PubMed ID: 22172956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]